DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

India Glycols announces Q2 and H1 FY27 earnings conference call

InvestyWise 2 hrs ago·6 Nov 2026, 10:12 am

India Glycols has announced its earnings conference call for the second quarter and the first half of fiscal year 2027. This is a routine update where the company management will discuss their financial performance, business strategy, and future outlook for the period.

For investors, this event is important as it provides clarity on the company's operational health and profitability. It offers a chance to understand how the company is navigating market conditions and helps in assessing its potential for growth in the coming quarters.

Investors should watch for details on production volumes, raw material costs, and the management's guidance for the remaining part of the fiscal year.